Prescribe to Save Lives: Improving Buprenorphine Prescribing Among HIV Clinicians-Reference-Cited by-同舟云学术

Prescribe to Save Lives: Improving Buprenorphine Prescribing Among HIV Clinicians

Published:2022-08-15 Issue:5 Volume:90 Page:546-552
ISSN:1525-4135
Container-title:JAIDS Journal of Acquired Immune Deficiency Syndromes
language:en
Short-container-title:

Author:

Jawa Raagini,Walley Alexander Y.,Wilson Donna J.,Green Traci C.,McKenzie Michelle,Hoskinson Randall,Bratberg Jeffrey,Ramsey Susan,Rich Josiah D.,Friedmann Peter D.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Infectious Diseases

Reference53 articles.

1. The syndemic of opioid misuse, overdose, HCV, and HIV: structural-level causes and interventions;Perlman;Curr HIV/AIDS Rep.,2018

2. HIV infection and risk of overdose: a systematic review and meta-analysis;Green;AIDS,2012

3. Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies;Sordo;BMJ,2017

4. A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence;Johnson;N Engl J Med.,2000

5. 1-year retention and social function after buprenorphine-assisted relapse prevention treatment for heroin dependence in Sweden: a randomised, placebo-controlled trial;Kakko;Lancet,2003

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Harm reduction stories: leveraging graphic medicine to engage veterans in substance use services within the VA;Harm Reduction Journal;2023-12-06

2. “I wouldn’t need Narcan for myself, but I can have it for somebody else:” perceptions of harm reduction among hospitalized patients with OUD;Addiction Science & Clinical Practice;2023-06-24

3. Facilitation and Preferred Models for Delivering Substance Use Disorder Treatment in HIV Clinics: Results From a Multisite Randomized Trial;Journal of Addiction Medicine;2023-06-16

4. Meeting the Moment: More Infectious Disease Physicians Must Be Prepared to Provide Buprenorphine;Clinical Infectious Diseases;2023-01-25

5. Prevalence, Distribution, and Characteristics Associated With Possession of Buprenorphine Waivers Among Infectious Diseases Physicians in the United States;Clinical Infectious Diseases;2022-11-24